Delpharm has inaugurated a new sterile filling line at its Saint-Rémy site to commit to French healthcare sovereignty. The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a result, Delpharm Saint-Rémy is significantly increasing its production capacity for sterile vials or freeze-drying with an additional capacity of 45 million units in 2 ml format. This investment, including a new building, is valued at €37 million, incl...